An Observational Study of Mircera (Methoxy Polyethylene Glycol-epoetin Beta) in Patients With Renal Anemia

Roche

Status: Completed

Conditions: Anemia

Treatments: Drug: methoxy polyethylene glycol-ep [Mircera]

Study type: Observational

Funder types: Industry

Identifiers

NCT01051323

ML22714

Details and patient eligibility

About

This observational study will investigate hemoglobin levels and Mircera (methoxy polyethyleneglycol-epoetin beta) dose over time in patients with chronic kidney disease, and compare standards of care between centers. Data from each patient will be collected over 12 months of Mircera therapy.

Enrollment: 1,580 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• adult patients, >/= 18 years of age
• chronic kidney disease
• informed consent for data transmission

Exclusion criteria

• serious hematological or infectious disease
• acute bleeding in the 16 weeks preceding data collection
• participation in an interventional trial
• female patients: pregnancy or breast-feeding

Trial design

1,580 participants in 1 patient group

1

Treatment:

Drug: methoxy polyethylene glycol-ep [Mircera]